Holen Sie sich die Stockscreener-App
2.45
1.24%
0.03
Handel nachbörslich:
2.50
0.05
+2.04%
Schlusskurs vom Vortag:
$2.42
Offen:
$2.43
24-Stunden-Volumen:
2.13M
Relative Volume:
0.58
Marktkapitalisierung:
$557.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-1.8421
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
-1.21%
1M Leistung:
-6.84%
6M Leistung:
+140.20%
1J Leistung:
+179.04%
1-Tages-Spanne:
$2.38
$2.52
1-Wochen-Bereich:
$2.2808
$2.53
52-Wochen-Spanne:
$0.6617
$3.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
Gossamer Bio Inc
Sektor
Branche
Telefon
(858) 684-1300
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.45 | 553.89M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-10 | Hochstufung | UBS | Neutral → Buy |
| 2025-07-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-19 | Eingeleitet | Wedbush | Outperform |
| 2022-04-18 | Eingeleitet | Raymond James | Outperform |
| 2022-04-06 | Eingeleitet | UBS | Buy |
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-30 | Eingeleitet | Berenberg | Buy |
| 2019-03-05 | Eingeleitet | Barclays | Overweight |
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform |
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
Is Gossamer Bio Inc. stock affected by interest rate hikesJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Why millennials buy Gossamer Bio Inc. (4GB) stockWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Is now a turning point for Gossamer Bio Inc.July 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Why Gossamer Bio Inc. (4GB) stock could outperform next year2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Will Gossamer Bio Inc. (4GB) stock keep raising dividendsJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Ranking Gossamer Bio Inc. among high performing stocks via toolsEarnings Beat & High Accuracy Buy Signal Tips - newser.com
What Wall Street predicts for Gossamer Bio Inc. stock price2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
How to use Fibonacci retracement on Gossamer Bio Inc.Product Launch & Weekly High Conviction Ideas - newser.com
Can momentum traders help lift Gossamer Bio Inc.Rate Cut & High Conviction Buy Zone Alerts - newser.com
What Fibonacci levels say about Gossamer Bio Inc. rebound2025 Price Momentum & High Return Stock Watch Alerts - newser.com
Is Gossamer Bio Inc. (4GB) stock nearing a technical breakout2025 Risk Factors & Expert Approved Trade Ideas - newser.com
Institutional Investors Control 62% of Gossamer Bio, Inc. (NASDAQ:GOSS) and Were Rewarded Last Week After Stock Increased 16% - 富途牛牛
Published on: 2025-10-31 05:26:53 - newser.com
Gossamer Bio (GOSS) to Release Quarterly Earnings on Thursday - MarketBeat
Does Gossamer Bio Inc. show high probability of reboundOptions Play & Free Community Supported Trade Ideas - newser.com
Using portfolio simulators with Gossamer Bio Inc. includedWeekly Loss Report & Free Fast Gain Swing Trade Alerts - newser.com
Why Gossamer Bio Inc. stock remains undervaluedJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Gossamer Bio Inc. stock recover faster than marketForecast Cut & Long-Term Growth Plans - newser.com
Is Gossamer Bio Inc. (4GB) stock supported by strong fundamentalsWeekly Loss Report & Fast Exit and Entry Trade Guides - newser.com
Analyzing net buyer seller activity in Gossamer Bio Inc.Weekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
Will Gossamer Bio Inc. (4GB) stock issue positive guidancePortfolio Value Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-29 05:37:17 - newser.com
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):